HIV&Hepatitis Drug Guide PRO

$14.99

3.0.2for iPhone, iPad

www.flsida.org

Developer

Aug 5, 2019

Update Date

Medical

Category

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

HIV&Hepatitis Drug Guide PRO Screenshots

iPad

iPhone

About HIV&Hepatitis Drug Guide PRO

**************************************************************************
This application has been developed for exclusive use by health professionals. If you are not biomedical personnel you should not download this application.
**************************************************************************

Management of HIV and viral hepatitis infections are ever-changing fields and
resistance to antiviral agents represents one major issue for the management of infected
patients.

This application provides instant and easy access to regularly updated information about
specific HIV, HCV and HBV mutations related to resistance to antiviral drugs. Both
in vitro and in vivo information is provided for each specific drug resistance mutation
selected by users.

This is an “offline” application that is downloaded to your device. An internet
connection is not required to use the application.

The application has been developed by Lluita contra la Sida Foundation through support
from Janssen.